Skip to content

Clinical trials

Observational Neuroinflammatory Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroinflammatory Diseases Phase: Observational Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20112
20121
20132
20141
20153
20161
20176
20187
20191
20202
20216
20223
20239
20246
20255
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting19
Unknown status9
Active, not recruiting3
Not yet recruiting3
Terminated3
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)4
Assistance Publique - Hôpitaux de Paris2
Brain Inflammation Collaborative2
Chelsea and Westminster NHS Foundation Trust2
Leiden University Medical Center2
Ludwig-Maximilians - University of Munich2
Alexandria University1
Ankara University1
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia1
Azienda USL Reggio Emilia - IRCCS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroinflammatory Diseases65
Cognitive Dysfunction7
Inflammation7
Alzheimer Disease6
Nerve Degeneration6
Nervous System Diseases5
Parkinson Disease5
Brain Diseases4
Brain Injuries, Traumatic4
Major Depressive Disorder4

Trials

Showing 51 to 65 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.